CoChat

The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression

Open access

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Childhood maltreatment is associated with a poor treatment response to conventional antidepressants and increased risk for treatment-resistant depression (TRD). The N-methyl-D-aspartate receptor (NDMAR) antagonist ketamine has been shown to rapidly improve symptoms of depression in patients with TRD. It is unknown if childhood maltreatment could influence ketamine’s treatment response. We examined the relationship between childhood maltreatment using the Childhood Trauma Questionnaire (CTQ) and treatment response using the Quick Inventory of Depressive Symptoms–Self Report (QIDS-SR) in TRD patients receiving intravenous ketamine at a community outpatient clinic. We evaluated treatment response after a single infusion (n = 115) and a course of repeated infusions (n = 63). Repeated measures general linear models and Bayes factor (BF) showed significant decreases in QIDS-SR after the first and second infusions, which plateaued after the third infusion. Clinically significant childhood sexual abuse, physical abuse, and cumulative clinically significant maltreatment on multiple domains (maltreatment load) were associated with better treatment response to a single and repeated infusions. After repeated infusions, higher load was also associated with a higher remission rate. In contrast to conventional antidepressants, ketamine could be more effective in TRD patients with more childhood trauma burden, perhaps due to ketamine’s proposed ability to block trauma-associated behavioral sensitization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ph12030133

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure A1 Subject response distributions of total CTQ and CTQ subscales. Clinically significant maltreatment cut-offs for each of the subscales are indicated by the red shaded areas. The number and percentage of subjects are as displayed in Table A1. There is no cut-off available for total CTQ.
Figure A1 Subject response distributions of total CTQ and CTQ subscales. Clinically significant maltreatment cut-offs for each of the subscales are indicated by the red shaded areas. The number and percentage of subjects are as displayed in Table A1. There is no cut-off available for total CTQ.CC BY · PubMed Central
Figure A2 CONSORT chart.
Figure A2 CONSORT chart.CC BY · PubMed Central
Figure 1 Time by maltreatment load interaction for QIDS-SR. QIDS-SR < 6 indicates remission.
Figure 1 Time by maltreatment load interaction for QIDS-SR. QIDS-SR < 6 indicates remission.CC BY · PubMed Central
Figure 2 Response and remission rates as a function of CTQ childhood or adolescent maltreatment load.
Figure 2 Response and remission rates as a function of CTQ childhood or adolescent maltreatment load.CC BY · PubMed Central
Figure 3 Study samples and schedule of procedures.
Figure 3 Study samples and schedule of procedures.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 33

Metadata

Authors
O’Brien, B., Lijffijt, M., Wells, A., Swann, A. C., & Mathew, S. J.
Affiliations
  • Michael E. DeBakey VA Medical Center (US)
  • Lone Star Infusion, PLLC, Houston, TX 77079, USA
Corresponding author
O’Brien, Brittany
Venue
Pharmaceuticals
Publisher
MDPI AG
Published
2019-09-11
Volume
12
Issue
3
Pages
133
ISSN
1424-8247 (ISSN-L)
OpenAlex
W2972990098
Cited by
33
References
47
Citations by year
2026: 2 · 2025: 6 · 2024: 6 · 2023: 7 · 2022: 3 · 2021: 6 · 2020: 3
FWCI
1.86
Type
journal article
Language
en
Open access
Locations
  • Pharmaceuticals (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
child abuse, treatment-resistant depression, intravenous ketamine, child sexual abuse, physical abuse, remission, NMDA receptor antagonists, antidepressant response

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.